Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong

Mok, Chris Ka Pun, Cohen, Carolyn A., Cheng, Samuel M. S., Chen, Chunke, Kwok, Kin‐On, Yiu, Karen, Chan, Tat‐On, Bull, Maireid +11 more·2022·Respirology

DOI 10.1111/resp.14191

Cited by (161)

Items 101–161 of 161

A 22 month prospective assessment of neutralizing and IgG antibody levels against SARS-CoV-2 variants following homologous and heterologous BNT162b2 boosting
Aini Syahida Mat Yassim, Anis Atifah Mohd Hisham, Nik Nur Atiqah Nik Daud, Nur Diana Anuar, Ti-Myen Tan, Rapeah Suppıan, Mat Jusoh Siti Asmaa, Amiratul Aifa Mohamad Asri, Maryam Azlan, Nur Suhaila Idris et al. · 2025 · Scientific Reports
SARS-CoV-2 Breakthrough Infection after mRNA-1273 Booster among CoronaVac-Vaccinated Healthcare Workers
Theresia Santi, Lina Kamarga, Baringin De Samakto, Juandy Jo · 2022 · Infection and Chemotherapy
Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
Mustafa Doğan, Berna Yılmaz · 2023 · Acta Pharmaceutica
Humoral immune response in people living with HIV after administration of SARS-CoV-2 vaccine CoronaVac or BNT162b2 or CoronaVac/BNT162b2 booster sequence: A cross-sectional study
Marcelo J. Wolff, Paulo Charpentier, Andrea Canals, Cecilia Vial, Juan Hormazábal, Jimena Cortés, Macarena Silva · 2023 · Vaccine
Immune Persistence against SARS-CoV-2 after Primary and Booster Immunization in Humans: A Large-Scale Prospective Cohort Study
Juan Li, Hui Xie, Weixin Chen, Meng Chen, Shuang Bai, Wei Zhao, Tao Zhou, Pei Gao, Lichi Zhang, Quanyi Wang et al. · 2022 · Vaccines
Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination
Lei Zhang, Jiaqing Yang, Min Deng, Chuanhui Xu, Changchun Lai, Xuanying Deng, Yan Wang, Qiang Zhou, Yichu Liu, Li Wan et al. · 2023 · Scientific Reports
Exploring the possible link between the spike protein immunoglobulin G4 antibodies and cancer progression
Mikolaj Raszek, David Cowley, Elrashdy M Moustafa Mohamed Redwan, Vladimir Nikolaevich Uversky, Alberto Rubio‐Casillas · 2024 · Exploration of Immunology
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Felipe Melo-González, Constanza Méndez, Hernán F. Peñaloza et al. · 2022 · medRxiv
Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients
Prapassorn Poolchanuan, Wasin Matsee, Adul Dulsuk, Rungnapa Phunpang, Chakkaphan Runcharoen, Thitiya Boonprakob, Onura Hemtong, Suchada Chowplijit, Vachara Chuapaknam, Tanaya Siripoon et al. · 2025 · Scientific Reports
COVID-19 vaccination and cerebral small vessel disease progression—A prospective cohort study
Bonaventure Yiu Ming Ip, Sangqi Pan, Alan Yao et al. · 2024 · International Journal of Infectious Diseases
Analysis of 65 Years Old and Over Patients with Full Dose Vaccination by Inactive Vaccine and without Vaccination Admitted to Hospital with SARS-CoV-2 PCR Positivity
Gürsel Ersan, Kazım Rollas, Sabri Atalay, Sarp Singil, Kamil Mert, Hilal Abakay, Nimet Şenoğlu, Süheyla Serin Senger, Şükran Köse · 2022 · Klimik Dergisi/Klimik Journal
Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
Chuancai Xu, Zhisong He, Wei Lei, Li Chen, Dan Shen, Xiaofei Wang, Deyu Xu, Ying Ming Xu, Jianan Huang · 2022 · BMC Infectious Diseases
The vaccination characteristics and mortal causes analysis of COVID-19 deaths at a district level
Melike Yavuz, Mehmet Akif Sezerol · 2023 · Journal of Medicine and Palliative Care
Antibody Response to SARS-CoV-2 Vaccination in Heart Failure Patients: Retrospective Single-Center Cohort Study
Defne Güneş Ergi, Ümit Kahraman, Gözde Akkuş Kayalı, Seyfi Durmaz, Özlem Balcıoğlu, Çağatay Engin, Burcu Yağmur, Sanem Nalbantgil, Candan Çiçek, Mustafa Özbaran et al. · 2023 · Diagnostics
Innovation-driven trend shaping COVID-19 vaccine development in China
Yuntao Zhang, Yuxiu Zhao, Hongyang Liang, Ying Ming Xu, Chuge Zhou, Yuzhu Yao, Hui Wang, Xiaoming Yang · 2023 · Frontiers of Medicine
Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac
Diego A. Díaz-Dinamarca, Simone Cárdenas-Cáceres, Nicolás A. Muena, Pablo Díaz, Gisselle N. Barra, Rodrigo Puentes, Daniel F. Escobar, Michal Díaz-Samirin, Natalia T. Santis-Alay, Cecilia Canales et al. · 2024 · Vaccines
The Advantage of Inactivated Vaccine for Preventing the Omicron Outbreak
Lian Xinbo, Jianping Huang, Li Zhang · 2022 · Preprints.org
Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report
Jennifer Cable, Siddharth Balachandran, Lisa P. Daley‐Bauer, Arjun Rustagi, Ferrin Antony, Justin J. Frere, Jamie Strampe, Katherine Kedzierska, Judy L. Cannon, Maureen Ann McGargill et al. · 2023 · Annals of the New York Academy of Sciences
Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 vaccines
Serkan Atıcı, Ahmet Soysal, Erdem Gönüllü, Gökhan Aydemir, Cevat Naci Oner, Servet Alan, Havva Engin, Melek Yıldız, Metin Karaböcüoğlu · 2023 · Revista da Sociedade Brasileira de Medicina Tropical
Methodical and Immunological Insights of Prime COVID-19 Vaccines
Wilson Pearl Evangeline, Sakthivelnathan Divyasri, Chandrasekaran Akshaya, Sekar Sruthi, Selvaraj Barathi, Rangasamy Kirubakaran, Kandasamy Nagarajan ArulJothi · 2023 · Coronaviruses
Re-Evaluation and Retrospective Comparison of Serum Neutralization Induced by Three Different Types of Inactivated SARS-CoV-2 Vaccines
Weiyu Jiang, Jianbo Wu, Jiaying He, Anqi Xia, Wei Wu, Yidan Gao, Qianqian Zhang, Xiaofang Peng, Qiaochu Jiang, Song Xue et al. · 2024 · Vaccines
Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses
Beatriz L. L. Caetano, Paolla Beatriz Almeida Pinto, Agatha R. Pacheco, Agnes R. Lage, Aline Pereira, Amanda V. P. Nascimento, Thiago R. Machado, Anderson Paulino, Thiago L. Medeiros, Lorena O. Fernandes-Siqueira et al. · 2025 · Frontiers in Immunology
Predicting the efficacy of new coronavirus vaccines – Are neutralising antibodies enough?
Elizabeth Miller · 2022 · EBioMedicine
COVID-19 After Vaccination in Lung Transplant Recipients: Real-Life Data
Sinan Türkkan, Fatmanur Çelik Başaran, Mehmet Furkan Şahin, Muhammet Ali Beyoğlu, Emre Kasim Yilmaz, Alkın Yazıcıoğlu, Hülya Yiğit Özay, Mustafa Bindal, Yasemin Tezer Tekce, Erdal Yekeler · 2022 · Experimental and Clinical Transplantation
Antibody response to different COVID-19 vaccines among the migrant workers of Bangladesh
Md. Imam Hossain, Protim Sarker, Rubhana Raqib, Md Ziaur Rahman, Rezaul Hasan, Chloe Svezia, Mahbubur Rahman, Nuhu Amin · 2023 · Frontiers in Immunology
Vaccine effectiveness against the B.1.617.2 in the intensive care unit
Ibrahim Koc, Sevda Unalli Ozmen, Olgun Deniz · 2023 · Medicine
Humoral and Cellular Immune Response after Three Doses of Sinopharm [Vero Cell]-Inactivated COVID-19 Vaccine in Combination with SARS-CoV-2 Infection Leads to Hybrid Immunity
Marija Vukčević, Katarina Šerović, Mateja Despot, Aleksandra Nikolić‐Kokić, Aleksandra Vujović, Milan R. Nikolic, Duško P. Blagojević, Tanja Jovanović, Dragana Despot · 2024 · Pharmaceuticals
Humoral Immune Response to CoronaVac in Turkish Adults
Yasemin Coşgun, Nergis Emanet, Ayten Öz Kamiloğlu · 2023 · Vaccines
The humoral and cellular immune response of a third dose adenoviral-based vectored vaccine after a single or 2 shots of inactivated COVID-19 vaccine in healthy adults
Supaporn Suparak, Kobkaew Bumroongthai, Danai Jantapalaboon et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Hybrid immunity after a natural infection and vaccination with Sinopharm [Vero Cell] - Inactivated COVID-19
Marija Vukčević, Katarina Šerović, Aleksandra Nikolić‐Kokić · 2023 · Preprints.org
Immunogenicity of BNT162b2 and CoronaVac boosters in fully vaccinated individuals with CoronaVac against SARS-CoV-2: A Longitudinal Study
Füsun Can, Zeynep Ece Kuloğlu, Rojbin El, Gülen Güney-Esken, Yeşim Tok, Zeynep Talay, Tayfun Barlas, Mert Ahmet Kuşkucu, Özgür Albayrak, Özlem Doğan et al. · 2022
Reply to Mungmunpuntipantip and Wiwanitkit: CoronaVac or BNT162b2 Vaccine as a Third Dose
Chris Ka Pun Mok, David S.C. Hui, Malik J. S. Peiris · 2022 · American Journal of Respiratory and Critical Care Medicine
Comparative epidemiology of ivermectin and vaccines against Delta variant based on real-world data and hypothesized mechanisms of ivermectin immunological action
Hisaya Tanioka, Sayaka Tanioka, Kimitaka Kaga · 2022 · Research Square
Predictors of Specific Cellular Immunity Response in Kidney Transplant Recipients After Administration of SARS-CoV-2 Inactivated Vaccine
Lei Zhang, Jiaqing Yang, Changchun Lai, Min Deng, Xuanying Deng, Yan Wang, Qiang Zhou, Yichu Liu, Li Wan, Pingchao Li et al. · 2022 · SSRN Electronic Journal
Vaccines for the Elderly
Daniel Cheung Shing Chiu · 2022 · Quality of life in Asia
COVID-19 Geçiren, CoronaVac ve BNT162b2 Aşı olan Bireylerde Hümoral İmmün Yanıtın Değerlendirilmesi
Nesrin Gareayaghi, Harika Öykü Dinç, Doğukan Özbey, Rüveyda Akçin, Ferhat Osman Daşdemir, Seher Akkus, Önder Yüksel Eryiğit, Bekir Kocazeybek · 2022 · Harran Üniversitesi Tıp Fakültesi Dergisi
Evaluation of Antibody Response and Side Effects Related to the Number of Inactive and mRNA Vaccine Doses Against COVID-19 in Healthcare Workers
Taylan Bozok, Harun GÜLBUDAK, Seda Tezcan Ülger · 2023 · Flora the Journal of Infectious Diseases and Clinical Microbiology
The Effect of Vaccination with Pfizer-BioNTech or CoronaVac on Disease Prognosis Among Hospitalized COVID-19 Patients
Mustafa Güldan, Sena Tuğana Ateş, Sebile Sarıoğlu · 2023 · Infectious Diseases and Clinical Microbiology
Evaluation of Quantitative IgG and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Turkey
Aylin İrem Ocaklı, Seyma Aybuke Ozyar Kurtcu, Mertcan Uzun, Merve Kasikci Cavdar, Gülçin Telli Dizman, Gökhan Metan, Murat Akova, Zeynep Sarıbaş, Burçin Şener · 2023 · Research Square
Evaluation of antibody and T Cell immunity response in different immunization groups of inactive and mRNA COVID-19 vaccines
Merve Zerey Albayrak, Süreyya Gül Yurtsever, Bilal Olcay Peker, Tuba Müderris, Selçuk Kaya · 2023 · Diagnostic Microbiology and Infectious Disease
The Vax effect: Role of global vaccination initiatives in pandemic control and impact in Dehradun during COVID-19
Ankita Singh, Nivedita Chetan Gurada, Nidhi Mahendru, Abhijeet Kashyap, Sourabh Bhanu, Narotam Sharma, Ritu Kaushik · 2024 · International Journal of Clinical Biochemistry and Research
Avaliação da resposta imunológica contra SARS-CoV-2 em grupos de risco vacinados com CoronaVac
Giuliana Xavier de Medeiros · 2023 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac
Zhangbiao Long, Suyu Jiang, Honglei Xin et al. · 2024 · Frontiers of Medicine
Immune Responses Against SARS-CoV-2 in Previously SARS-CoV-2-Infected Individuals after Receiving a Single Dose of CoronaVac or ChAdOx-1 Vaccine
Witida Laopajon, Athavudh Deesomchok, Warawut Chaiwong, Nuchjira Takheaw, Supansa Pata, Pilaiporn Duangjit, Juthamas Inchai, Chaicharn Pothirat, Chaiwat Bumroongkit, Theerakorn Theerakittikul et al. · 2025 · Infection and Chemotherapy
Comparison of SARS-CoV-2 IgG responses in hemodialysis patients and healthcare workers after COVID-19 vaccination
Hakkı Öztürk, Metin Özsoy, Ayşegül Tuna · 2025 · Frontiers in Immunology
Human indels as predictors of antibody responses to COVID-19 vaccines
Hsiuyi V. Chen, Siew‐Wai Fong, Yun Shan Goh, Matthew Zirui Tay, Angéline Rouers, Zi Wei Chang, Andrea Wei Ming Chua, Liang Hui Loo, Jean‐Marc Chavatte, Raymond Tzer Pin Lin et al. · 2025 · iScience
Estimates of SARS-CoV-2 vaccine effectiveness against outpatient medically attended SARS-CoV-2 infection from April 2023 through August 2024 in Hong Kong: A test-negative design study
George N. Okoli, Caitriona Murphy, Loretta Mak · 2025 · Vaccine
Additional file 6 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
Additional file 1 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
Additional file 4 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
Additional file 7 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
Additional file 2 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang, Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
Additional file 5 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
Additional file 3 of Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
Xu, Chuancai, He, Zhisong, Lei, Wei, Chen, Li, Shen, Dan, Wang, Xiaofei, Xu, Deyu, Xu, Ying, Huang, Jian’an · 2022 · Figshare
Additional file 1 of A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran
Ghafari, Mahan, Sepanta Hosseinpour, Rezaee-Zavareh, Mohammad Saeid, Stefan Dascalu, Somayeh Rostamian, Kiarash Aramesh, Madani, Kaveh, Kordasti, Shahram · 2024 · Figshare
Prospective Evaluation of Antibody Response post COVID-19 vaccination in older persons ≧ 60 years old (PEARL 60): A longitudinal 15-months study in a tertiary centre in Malaysia
Kejal Hasmukharay, Ashutosh Kumar Verma, Kiirtaara Aravindhan, Prakhaash Raaj S. Alagappan, Aisya Karynna Md Kamal, Nurul Syuhada Zulhaimi, Nor Izzati Saedon, Jamal I-Ching Sam, Tan Maw Pin, Reena Rajasuriar · 2026 · PLoS ONE
SARS-CoV-2 Anti-Spike IgG Subclass Titres in a Population with Prior Exposure to Perfluorooctanoic Acid (PFOA)
Mihai Zamfir, Doris G. Gerstner, Heidi Lahne, Volker Fingerle, Johannes Redwitz, Wolfgang Schöber, Bettina Aschenbrenner, Matthias Graw, Dennis Nowak, Caroline Quartucci et al. · 2026 · Toxics
Comparative effectiveness of COVID-19 vaccines among health students, focusing on methodological concerns
Banu Topçu Çakir, Ahmet Sertcelik, Eda Karadoğan et al. · 2026 · Antimicrobial Stewardship & Healthcare Epidemiology
Seroprevalence of COVID-19 among healthcare workers in Hong Kong during the first 2 years of the COVID-19 pandemic (2020–2021): a longitudinal cohort study
Wey Wen Lim, Loretta Mak, Faith C. S. Ho et al. · 2026 · BMJ Open
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: A non-inferiority, randomized, double-blind, phase IV clinical trial in Pakistan
Huma Syed Hussain, Mohammad Tahir Yousafzai, Junaid Iqbal et al. · 2026 · Vaccine
Differential prolonged multiomic responses to mRNA and inactivated virus COVID-19 vaccines
Hein Min Tun, Shilin Zhao, Chunke Chen, Yuzhou Chen, Ye Peng, Huibin Lv, Jie Zhu, Yun Sang Tang, Ken KP Chan, Bonaventure Y. Ip et al. · 2026 · Cellular and Molecular Life Sciences